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ABSTRACT
Objectives: The aim of the study was to assess the outcome of vesico-amniotic shunting performed before 16 weeks of 
pregnancy in fetuses with severe megacystis diagnosed in the first trimester of pregnancy.
Material and methods: Between January 2008 and October 2012 severe megacystis with the bladder length > 15 mm was 
diagnosed in 17 fetuses. The procedure of early vesico-amniotic shunting (VAS) was offered to 8 patients with presumably 
isolated LUTO. 
The procedure of VAS was performed in 6 fetuses. Before the intervention one or two procedures of vesicocentesis and 
urine analysis were performed.
Results: In all treated cases shunts provided urinary tract decompression. All babies were born prematurely, 2 of them died 
due to premaurity, 3 of them survived and have normal renal function at the age of 5–6 years. In 4/5 children accompanying 
malformations were later diagnosed, in 1 born prematurely neonate necropsy was not performed. 
Conclusions: Our results suggest that early vesico-amniotic shunting in fetal LUTO is feasible and may potentially prevent 
not only pulmonary hypoplasia but also renal insufficiency. However, the rationale of the procedure needs further inves-
tigation due to a high risk of long-term morbidity and co-existing malformations in children Before offering the therapy 
detailed counseling of the parents about the possible pros and cons of the therapy is necessary.
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INTRODUCTION
Lower urinary tract obstruction (LUTO) is a heterogene-
ous group of fetal urethral anomalies that eventually lead 
to cystic renal dysplasia, oligo- or anhydramnios and lethal 
pulmonary hypoplasia. LUTO, usually in form of posterior 
urethral valves (PUVs) or urethral atresia, is more prevalent 
in male than in female fetuses [1–2]. Depending on the 
cause and degree of urethral obstruction, LUTO may be 
associated with 45–100% prenatal mortality [3], and even 
postnatal survivors often develop end-stage chronic renal 
impairment [4]. Fetal LUTO can be suspected as early as at 
11–14 weeks of gestation on the basis of the urinary blad-
der enlargement, referred to as megacystis, especially when 
the fetal bladder length exceeds 15 mm [5]. Percutaneous 
vesico-amniotic shunting with drainage of fetal urine to 
the amniotic cavity, is the most common intervention in 
LUTO fetuses [6] The second option is fetal cystoscopy with 
laser fulguration of PUVs. Although LUTO can be suspected 
already in the first trimester of pregnancy, both treatment 
procedures are usually postponed after 16 weeks due to 
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technical limitations and until the definitive diagnosis is 
established and renal function is verified [7]. As a result of 
this management, many fetuses with severe LUTO present 
with significant impairment of renal function at the time of 
diagnosis which either precludes intervention or causes later 
renal insufficiency. This management may increase perinatal 
survival of poor prognosis fetuses in which renal damage 
already occured only by preventing pulmonary hypoplasia 
caused by oligo- or anhydramnios. Owing limitations of 
treatment of LUTO performed after 16 weeks we offered 
earlier intervention in some eligible cases. We present here 
the outcomes of 17 consecutive pregnancies complicated by 
early diagnosed severe megacystis. Specifically, we focused 
on prenatal and postnatal outcomes of fetuses with LUTO 
subjected to early vesicocentesis combined with percutane-
ous vesico-amniotic shunting before 16 weeks of gestation.
MATERIAL AND METHODS
Our series included 17 cases of severe fetal megacys-
tis diagnosed in our department on routine ultrasound 
at 11–14 weeks of gestation between January 2008 and 
October 2012.
All fetuses with severe megacystis (fetal bladder 
length > 15 mm) were subjected to detailed ultrasono-
graphic and echocardiographic examination to exclude 
potential co-existing malformations. Chorionic villus sam-
pling was performed in every case to reveal fetal karyotype. 
Isolated LUTO was suspected whenever severe megacystis 
without other apparent concomitant malformations was 
found on routine ultrasound at 11–14 weeks of gestation. 
Such cases were considered eligible for early intrauterine 
intervention. The parents were informed about potential 
risks and benefits of the treatment, as well as about pos-
sible long-term outcomes in their children. The treatment 
was commenced only when written informed consent was 
obtained from a pregnant woman.
The protocol of the study was approved by the Act No. 
18/PB/2013 of the Local Bioethics Committee at the Medical 
Center of Postgraduate Education, and all pregnant women 
gave their written informed consent prior to any procedure.
Before the intervention one or two procedures of vesi-
cocentesis with a 22-gauge (G) needle was performed. 
Urine evacuated during the procedure was subjected to 
analysis in order to determine actual fetal renal function. 
This procedure allowed also early decompression of the 
urinary bladder. In all fetuses megacystis recurred despite 
1–2 sequential vesicocenteses. 
All the procedures of vesico-amniotic shunting were 
performed under ultrasound guidance with local or regional 
anesthesia of a pregnant woman. A double pig-tail Harrison 
shunt (Fetal Bladder Stent Set, Cook Medical, Inc., 1.67 mm in 
diameter) was introduced to fetal bladder via a 14-G needle. 
Double coiled end of the shunt was placed in fetal bladder 
whereas the single coiled end was left in amniotic cavity. In 
two cases due to logistic reasons the procedure of shunting 
was performed before fetal karyotype was obtained. The 
patients were informed, that if there is abnormal karyotype 
the pregnancy can be terminated on their request regardless 
of the procedure performed.
Patients subjected to vesico-amniotic shunting were 
monitored ultrasonographically every two weeks for poten-
tial shunt dislocation and other complications. The shunting 
was repeated whenever necessary. Amniotic ﬂuid volume, 
fetal bladder and kidneys were also assessed.
After delivery, all survivors were examined by urolo-
gists and pediatricians. Micturating cystourethrography 
and postnatal cystoscopy were used to evaluate the bladder 
and the urethra, as well as the residual valvular tissue, when 
necessary. Then the infants were continuously followed-up 
after birth. Serum creatinine measurements were used to 
determine renal function. An abnormal renal function was 
considered whenever serum creatinine was elevated or if 
dialysis or renal transplantation was necessary. Autopsy was 
performed when fetal or neonatal death occurred.
RESULTS
Preintervention data
In 7/17 cases pregnancies were terminated on parental 
request due to trisomy 18 (n = 3), concomitant heart defect 
(n = 2) or presumed poor prognosis (n = 2). Another 2/17 fe-
tuses were miscarried spontaneously before 16 weeks.
Intrauterine intervention
Only 8/17 fetuses with severe megacystis were poten-
tially eligible for intrauterine intervention and their parents 
gave consent to the treatment (Fig. 1). 
A single or double vesicocentesis was performed in 
7/8 fetuses between 12 and 14 weeks and fetal urine was 
subjected to analysis in 6/7 cases. Another fetus was miscar-
ried within a week from the vesicocentesis. 
The procedures of bladder shunting were finally per-
formed in 7/17 fetuses between 14.3 and 15.6 weeks of 
gestation (Figs. 2, 3). 
The group subjected to vesico-amniotic shunting in-
cluded 6 fetuses from singleton pregnancies and one fetus 
from twin monochorionic monoamniotic (MCMA) preg-
nancy (Case no. 3). Although twin pregnancies, especially 
MCMA, are usually considered a relative contraindication 
for such invasive procedures, we performed the shunting 
owing parental request. No intraoperative complications 
were recorded in any case. As oligohydramnios is typically 
not observed in LUTO before 16 weeks of pregnancy, amnio-
infusion was not needed to correctly insert the shunt to the 
amniotic cavity. Preterm premature rupture of membranes 
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(PPROM) occurred in one case (Case no. 6) within a week 
from the shunting. The result of genetic analysis which 
was available after the procedure revealed trisomy 18 and 
the pregnancy was terminated. Postmortem examination 
showed that aside from complete LUTO, the fetus presented 
with cleft palate. 
Prenatal follow-up
All 6 treated fetuses required repeated shunting at 
18.1–34.6 weeks due to shunt displacement and resultant 
severe oligohydramnios. The presence of oligohydramnios 
confirmed the diagnosis of complete LUTO. In two fetuses 
(Cases no. 2 and 4), amniotic end of the shunt displaced to 
the abdominal cavity and urinary ascites developed. In Case 
no. 2, the displaced shunt caused iatrogenic gastroschisis 
which surprisingly allowed effective drainage of the abdomi-
nal cavity. In Case no. 4 another shunt needed to be placed 
in the abdominal wall due to massive urinary ascites. As 
it also underwent displacement, a coronary stent (Integ-
rity, 3.5 × 12 mm) was implanted to the abdominal wall at 
21 weeks of gestation to provide a free urine outflow (Fig. 4). 
Although the procedure was successful and the stent 
remained in place until birth, it provided drainage for no 
longer than 10 days and then was obstructed by fetal con-
nective tissue. Therefore, we eventually decided on sequen-
tial abdominocenteses with subsequent amnioinfusion of 
fetal urine. Other anomalies were observed in later preg-
nancy in two fetuses — a slight unilateral hydrothorax (Case 
no. 5). and bowel distension and polyhydramnios in the third 
trimester (Case no. 3) (Table 1).
Delivery and postnatal follow-up
All six treated prenatally neonates were born prema-
turely. Four of them were delivered by caesarean section 
after 31 weeks of gestation after steroid administration 
to enhance lung maturity (range 31.3–34.6 weeks) and all 
of them survived. The indications for caesarean section 
Figure 1. 13 weeks fetus with megacystis in the first trimester. 
Bladder length of 36 mm (case 1)
Figure 2. 15 weeks fetus after vesico-amniotic shunting. Shunt visible 
in fetal bladder (case 1)
Figure 3. 15 weeks fetus after early vesico-amniotic shunting. 
External part of the shunt visible in front of the fetal abdomen below 
the fetal elbow (3D US, case 1)
Figure 4. Coronanry stent inserted in the fetal abdominal wall
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included shunt displacement at 34.6 weeks (Case no. 1), 
uterine contractions after PPROM due to polyhydramnios 
at 31.3 weeks (Case no. 2), umbilical cord entanglement in 
MCMA pregnancy at 33.5 weeks (Case no. 3) and cardiotoco-
graphic evidence of fetal asphyxia at 34.5 weeks (Case no. 4). 
Two other babies were delivered extremely prematurely and 
died. One neonate (Case no. 5) was delivered spontaneously 
due to cervical incompetence at 25.6 weeks and died in the 
first day of life because of extreme prematurity. We have no 
data on the second neonate (Case no. 6). 
Complete LUTO due to PUVs (Cases no. 1 and 3) or urethral 
atresia (Cases no. 2 and 4), was confirmed postnatally in all 
the survivors (Table 2). In Case no. 1 LUTO co-existed with 
right kidney hypoplasia. Two neonates (Cases no. 2 and 3) 
presented with right kidney hypoplasia and anal atresia. In 
Case no. 4 atypical diffuse bowel stricture was observed after 
Table 2. Children born alive with LUTO after vesico-amniotic shunting — follow-up
Case 
number Urinary tract abnormalities
Other organs 
abnormalities Interventions in the neonatal period
Age (years)/serum 
creatinine [mg%]
1
PUVs
Bilateral vesicoureteral reflux
Right kidney hypoplastic
None
Vesicostomy until resection of PUVs
PUVs resection
Unilateral nephrostomy because of  
vesico-ureteral reflux
6/0.57
2 Urethral atresiaRight kidney hypoplastic
Anal atresia
Sacral agenesis
Permanent vesicostomy
Permanent colostomy 6/0.29
3 PUVs, Right kidney hypoplastic Anal atresia
Temporary vesicostomy
and colostomy 5/0.66
LUTO — lower urinary tract obstruction; PUVs — posterior urethral valves
Table 1. Fetuses undergoing vesico-amniotic shunting prior to 16 weeks — perinatal history
Case 
number
Time of diagnosis 
(GA in weeks / 
/bladder length) 
[mm]
Shunt 
placement 
(GA in weeks)
Shunt displacement/secondary shunt 
(GA in weeks)
Mode of delivery, indication for delivery/ 
/(GA in weeks)/birth weight(g)/ 
/Apgar score
Karyotype
1 12/42 15.4 2734.6
CS, shunt displacement 
34.6 
2640 g/7
46,XY
2 13.4/37 15.5
25.4 abdomino-amniotic shunt,
25.6 shunt dislocation,
draining gastroschisis
CS, PROM since 30 weeks + contractions
31.3
2160 g/6
46,XY
3 
Twins MCMA 12/26 15.1
18.1 dislocation to the amniotic cavity, 
vesico amniotic shunt
22.1 dislocation to the abdomen, 
abdomino-amniotic shunt
CS, umbilical cord entanglement
33.5
twin I 2130 g (with LUTO)/10/46, XY,  
twin II 1940 g/10/46, XY
4 13.6/64 14.1
17.0 shunt dislocation to the abdomen
18.0 and 26.3 abdomino-amniotic shunts
21.1 stent into abdominal wall 
From 26.6 weeks — 24 abdominal cavity 
punctures
CS, decelerations in CTG, PROM at 33 weeks
34.5
1950 g/2
46,XY
5 13.5/28 14.5 14.5
VB, PPROM — cervical incompetence 25.6
690/2 
46,XY
Death at first day of life
6 13.5/42 14.4, PPROM –
TOP, PPROM 
15.0  
autopsy: PUV, cleft palate; 47,XY,+18
7 15.4/47 – –
VB 
neonatal death due to prematurity
No follow up data
GA — gestational age; Cs — cesarean section; PROM — preterm rupture of membranes; MCMA — monochorionic monoamniotic; LUTO — lower urinary tract 
obstruction; CTG — cardiotocography; VB — vaginal birth; PPROM — premature preterm rupture of membranes; TOP — termination of pregnancy; PUV — posterior 
urethral valve
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birth. We were unable to differentiate the cause of LUTO in 
Case no. 5 due to technical difficulties during necropsy and in 
Case no. 6 due to lack of follow up. However, the post-mortem 
evidence of mild left-sided hydrothorax in Case no. 5 sug-
gested that also in this case LUTO was not an isolated defect. 
All 4 neonates required surgical intervention after birth: 
PUV removal with ureterocutaneostomy due to vesicoureter-
al reflux (Case no. 1), vesicostomy (Cases no. 2, 3 and 4), 
colostomy (Cases 2 and 3) and gastrostomy (Case no. 4). The 
baby with additional intestinal problems (Case no. 4) died 
at the age of 1 month. 
Three boys (Cases no. 1, 2 and 3) are alive, present with 
normal renal function at 6 years (case 1 and 2) and 5 years 
(case 3). Only one of them (Case no. 1) urinates freely, two 
other need vesicostomy and colostomy due to urethral and 
anal atresia and are awaiting repairing surgery in the future.
DISCUSSION
Prenatal interventions for LUTO is a widely debated 
problem. The rationale for in utero treatment is based on 
the possibility of removing the obstruction in the urethra 
and preventing renal damage as well as pulmonary hypo-
plasia by restoring the amniotic fluid volume. Generally, 
vesico-amniotic shunting is considered feasible in fetuses 
from singleton pregnancies > 16 weeks presenting with 
isolated LUTO [7]. However, long-term results of second 
and third trimester urinary shunting for LUTO have been 
disappointing because the renal tissue in fetuses with severe 
LUTO seems to be damaged long before the intervention is 
usually performed. Nephrogenesis is mostly complete by the 
end of the first half of the pregnancy and in severe cases it 
is unlikely that urinary system decompression allows kidney 
regeneration. In contrast based on literature [8], long-term 
survival and morbidity of fetuses with mild forms of LUTO 
appears unchanged by fetal intervention. 
On the other hand, yet published data on the outcomes 
of the early procedures are sparse. Only a few authors re-
ported the results of early VAS performed before 16 weeks 
of gestation and its efﬁcacy in improving the perinatal sur-
vival rate has not been proved. Usually, fetuses subjected 
to the early intervention were miscarried shortly thereafter 
or pregnancies were terminated due to later identification 
of additional malformations [9–11].
However, there are a few published case reports of chil-
dren with LUTO that were subjected to early vesico-amniotic 
shunting and survived until birth with normal renal function 
what raises the question of the benefit of an earlier treat-
ment [12–15].
The procedure of vesicoamniotic shunts is far from ideal 
as it has many disadvantages, like erroneous placement, 
displacement, urinary ascites formation and affecting blad-
der function because presence of shunts preclude a normal 
urination cycle [16–18]. 
Despite those difficulties, due to technical reasons VAS 
seems to be the most feasible option for fetuses in the early 
pregnancy.
Another option of intervention in presumed LUTO is an-
tegrade fetal cystoscopy. The main advantage of cystoscopy 
is that it potentially allows to perform the diagnosis of the 
type of the obstruction and provides physiological drainage 
of the urinary bladder. The procedure, similar to early VAS, 
does not require amnioinfusion, but is usually performed 
after 16 weeks of pregnancy [19]. 
Although the experience with this procedure is still limit-
ed, general neonatal outcomes of this procedure seem to be 
slighty better after cystoscopy then after VAS. Some authors 
found an improvement in survival at 6 months after either 
fetal intervention (cystoscopy and VAS) and a marginal ad-
vantage of fetal cystoscopy for renal function. Unfortunately, 
antegrade cystoscopy has also significant drawbacks. The 
time of the procedure is later in pregnancy, it is more dif-
ficult than early vesico-amniotic shunting, requires special 
equipment and may result in severe complications, like fetal 
death or development of urological fistulas [20]. 
Another vital issue which should be discussed is qual-
ification for the procedure. This is a general problem of 
in-utero interventions in fetuses with LUTO, because some 
developmental malformations, like anal atresia, cannot be 
detected until late pregnancy, even despite fetal karyotyp-
ing and detailed ultrasonographic evaluation. 
All our 7 procedures of early VAS were successful and 
only one pregnancy included in our series were terminated 
due to PPROM (in a fetus with trisomy 18). Also the pro-
cedure performed in a fetus from MCMA pregnancy was 
successful and uneventful (Case no. 3). Our observations 
confirm that the procedure of early VAS if technically feasible 
but has many disadvantages that limit its application. All 
our fetuses required repeated shunting due to the shunt 
displacement, a complication frequently reported in lit-
erature [7]. In our series of 17 cases of severe megacystis 
only as 3/6 fetuses treated with VAS survived after birth 
and still present with normal renal function at the age of 
5–6 years. Unfortunately 2/3 of them suffers from long term 
morbidity associated with urethral and anal atresia. 
However, a question arises which is better: expectant 
approach at the expense of progressively deteriorating renal 
function [21], or early intervention with a high likelihood 
of normal renal function in the future. While the answer 
seems obvious from subjective parental perspective, also 
our objective findings seem to favour the early intervention 
since all survivors present with normal renal function at the 
age of 5–6 years.
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As this study was based on a small series of cases, its re-
sults does not allow us to formulate any definitive conclusions 
about the value of early vesico-amniotic shunting in fetuses 
with presumed LUTO. However, even taking into account all 
potential limitations, the results of this study suggest that 
early vesico-amniotic shunting can be considered on pa-
rental request in selected fetuses. Unfortunately, the results 
presented in this series reflect the limit of an earlier interven-
tion, since it is not possible at this stage neither to determine 
the cause of LUTO nor to investigate precisely for associated 
anomalies. Although early intervention seems to prevent 
renal damage, the general prognosis in early severe LUTO is 
rather poor due to long-term morbidity and therefore con-
servative treatment or even pregnancy termination may be 
considered instead of any form of intrauterine intervention 
Taking into consideration the indisputable value of causa-
tive treatment which is relieving of the obstruction in fetal 
urethra and restoring the normal micturition in the fetal life 
in fetuses after early VAS other procedure like fetal cystoscopy 
or catheterization could be considered in later pregnancy, 
when it becomes technically possible [9, 10, 22, 23].
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